• Skip to main content
  • Skip to main content
Choose which site to search.
University of Arkansas for Medical Sciences Logo University of Arkansas for Medical Sciences
Research and Innovation: Institutional Review Board
  • UAMS Health
  • Jobs
  • Giving
  • About
    • Compliance Statement
    • Full Board Meetings
      • Committee Rosters
    • Institutional Review Board Blogs
    • Institutional Review Board Staff
    • Join the UAMS Institutional Review Board
    • Review Fees
  • CLARA
    • Access the System
    • Request a Human Subjects Research Determination
    • Start a Study
  • Templates, Training and Tools
    • Consent for Non-English Speakers
    • Events and Deviations Tables
    • Expanded Access Programs: Compassionate Use & Emergency Use
    • Human Subject Protection Training Instructions
  • Reporting to the Institutional Review Board
  • Expanded Access
  • Institutional Review Board Policies
    • Current Institutional Review Board Policies
      • 1 Principles and Authority
      • 2 Relationships
      • 3 Committee Membership
      • 4 Institutional Review Board Operations
      • 5 Records (Retired)
      • 6 Documentation
      • 7 Procedures for Study Review
      • 8 Change in Protocol
      • 9 Institutional Review Board Decisions
      • 10 Principal Investigator Responsibilities
      • 11 Appeals and Reconsiderations (retired)
      • 12 Quality Assurances
      • 13 Confidentiality
      • 14 Recruitment Practices
      • 15 Consent
      • 16 Risk / Benefit Analysis (moved)
      • 17 Special Populations
      • 18 Drugs and Devices
      • 19 Human Genetics Guidance
      • 20 Questions, Concerns, Suggestions and Complaints
    • Institutional Review Board Policy Archives
      • 1 Principles and Authority Archive
      • 2 Relationships Archive
      • 3 Committee Membership Archive
      • 4 Institutional Review Board Operations Archive
      • 5 Records Archive
      • 6 Documentation Archive
      • 7 Procedures for Study Review Archive
      • 8 Change in Protocol Archive
      • 9 Institutional Review Board Decisions Archive
      • 10 Principal Investigator Responsibilities Archive
      • 11 Appeals and Reconsiderations Archive
      • 12 Quality Assurances Archive
      • 13 Confidentiality Archive
      • 14 Recruitment Practices Archive
      • 15 Consent Archive
      • 16 Risk / Benefit Analysis Archive
      • 17 Special Populations Archive
      • 18 Drugs and Devices Archive
      • 19 Human Genetics Guidance Archive
      • 20 Questions, Concerns, Suggestions, Complaints Archive
  • Research Resources
    • Acronyms and Resources
    • FAQs
      • CITI Program FAQs
      • CLARA FAQs
      • Does my project need IRB review?
      • Prereview and Review Process FAQs
      • Reporting FAQs
      • Submission FAQs
    • Single / Central Institutional Review Board Review
  • Human Research Protection Program Plan
  1. University of Arkansas for Medical Sciences
  2. Research and Innovation
  3. Institutional Review Board
  4. Additional review for some studies

Additional review for some studies

The UAMS Research Legal Office has advised that some types of human subject research may not be allowable under recent federal and state requirements related to diversity, equity, and inclusion measures.

These restrictions apply to both new studies and to those that are ongoing, per information provided by research legal.

The following information was provided by the office of general counsel and indicates possible non-compliance with federal and state laws: 

  • Using DEI or other euphemistic terms.
  • Substituting neutral criteria for protected characteristics (race, sex, color, religion, and national origin) with the intention of advantaging or disadvantaging individuals based on these characteristics.  Geographic or Institutional Targeting appears neutral but implements recruitment strategies targeting specific geographic areas, institutions, or organizations primarily because of racial or ethnic composition.
  • Studying a population based on race or sex that would provide a benefit or advantage to that population in a way that disadvantages other populations.  Example: study of a specific population from a low resource area who smoke is non-compliant because there are other groups that smoke from this area.
  • Using federal funds in the form of a subaward to support third-party programs that discriminate. 

Investigators are asked to review their new and ongoing projects to assess compliance with these new requirements. If you have questions about this review in general or about a particular protocol, please contact Dr. Dan Voth (dvoth@uams.edu) for more information. The IRB office, when reviewing your submissions, may also advise you to consult Dr. Voth regarding a particular study.

Please note that if you have made changes to a study at the request of a funder to comply with new regulatory requirements, those changes must be submitted to the IRB for review and approval before implementation.

Posted by Edith Paal on December 1, 2025

Filed Under: Blog, Institutional Review Board Members, Research News

University of Arkansas for Medical Sciences LogoUniversity of Arkansas for Medical SciencesUniversity of Arkansas for Medical Sciences
Mailing Address: 4301 West Markham Street, Little Rock, AR 72205
Phone: (501) 686-7000
  • Facebook
  • X
  • Instagram
  • YouTube
  • LinkedIn
  • Pinterest
  • Disclaimer
  • Terms of Use
  • Privacy Statement
  • Legal Notices

© 2026 University of Arkansas for Medical Sciences